## Publications

- Editorial (September 21)
    - Shafer R. “A SARS-CoV-2 antiviral therapy score card” _Global Health & Medicine_, 2020. [doi.org/10.35772/ghm.2020.01082](https://doi.org/10.35772/ghm.2020.01082).
- Paper (September 4)
    - Tzou PL, Tao KM, et int., and Shafer R. “Coronavirus Antiviral Research Database (CoV-RDB): An Online Database Designed to Facilitate Comparisons between Candidate Anti-Coronavirus Compounds” _Viruses_, 2020. [doi.org/10.3390/v12091006](https://doi.org/10.3390/v12091006). \[[PubMed32916958](https://www.ncbi.nlm.nih.gov/pubmed/32916958/)\].

## Webinars

- October 2
    - Monoclonal Antibodies for the Prevention and Treatment of COVID 19. October 2, 2020. Robert Shafer, MD, Professor of Medicine, Division of Infectious Diseases, Stanford University. ([video](https://www.youtube.com/watch?v=YUj9jBlTCrY))
- August 10
    - SARS-CoV-2 Antivirals: Remdesivir and other Polymerase Inhibitors. August 10, 2020. Robert Shafer, MD, Professor of Medicine, Division of Infectious Diseases, Stanford University. ([video](https://stanford.cloud-cme.com/default.aspx?P=0&EID=38044))

